News and events

Family foundation gift allows University of Sydney in partnership with Chris O'Brien Lifehouse to establish inaugural Lang Walker Family Foundation Chair in Head and Neck Cancer Reconstructive Surgery.

Philanthropy provides major support for developing immunotherapy to treat cancer and other immune-related diseases.

The Cancer Council of NSW has awarded its annual Translational Program Grant to a Sydney-led project aiming to match ovarian cancer patients with the treatment or clinical trial most likely to work for their cancer subtype.

The University of Sydney has been awarded more than $26m for critical research into cardiovascular disease, brain cancer, autism, and to trial a vaccine for zoonotic disease, Q fever.

Researchers have found current estimates of lifetime risks of cancer diagnosis and mortality consistently higher than when they allowed for competing causes of death.

Why does a cancer treatment work for one person and fail for another, even if it's the same type of cancer? The fact is, the same cancers can have different protein signatures. ProCan's aim is to use this insight to select the best treatments.

Sydney researchers have evaluated the effectiveness of advanced mammography technology, finding improvements for breast cancer detection but cautioning it's too soon to tell if it will lead to better health outcomes.

Tumour tracking systems could be a global game changer for cancer treatment. They make imaging and radiotherapy more precise and safer for patients and could be used by cancer centres worldwide.